New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists

The activation of the human cannabinoid receptor type II (CB2R) is known to mediate analgesic and anti-inflammatory processes without the central adverse effects related to cannabinoid receptor type I (CB1R). In this work we describe the synthesis and evaluation of a novel series of N-aryl-2-pyridon...

Descripción completa

Detalles Bibliográficos
Autores principales: Faúndez-Parraguez, Manuel, Alarcón-Miranda, Carlos, Cho, Young Hwa, Pessoa-Mahana, Hernán, Gallardo-Garrido, Carlos, Chung, Hery, Faúndez, Mario, Pessoa-Mahana, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537746/
https://www.ncbi.nlm.nih.gov/pubmed/34681877
http://dx.doi.org/10.3390/ijms222011212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537746/
https://www.ncbi.nlm.nih.gov/pubmed/34681877
http://dx.doi.org/10.3390/ijms222011212

Ejemplares similares